Back to Browse Journals » Vascular Health and Risk Management » Volume 5

Prognostic stratification of acute pulmonary embolism: Focus on clinical aspects, imaging, and biomarkers

Authors Luca Masotti, Marc Righini, Nicolas Vuilleumier, Fabio Antonelli, et al.

Published Date July 2009 Volume 2009:5 Pages 567—575

DOI http://dx.doi.org/10.2147/VHRM.S4861

Published 2 July 2009

Luca Masotti1, Marc Righini2, Nicolas Vuilleumier3, Fabio Antonelli4, Giancarlo Landini5, Roberto Cappelli6, Patrick Ray7

1Internal Medicine, 4Clinical Chemistry, Cecina Hospital, Cecina, Italy; 2Division of Angiology and Haemostasis, Department of Internal Medicine, Geneva University Hospital, Switzerland; 3Division of Laboratory Medicine, Department of Genetics and Laboratory Medicine, Geneva University Hospitals and University of Geneva, Switzerland; 5Internal Medicine, Santa Maria Nuova Hospital, Florence, Italy; 6Thrombosis Center, University of Siena, Siena, Italy; 7Department of Emergency Medicine, Centre Hospitalo-Universitaire Pitié-Salpêtrière, UPMC Paris 6, Paris, France

Abstract: Pulmonary embolism (PE) represents a common disease in emergency medicine and guidelines for diagnosis and treatment have had wide diffusion. However, PE morbidity and mortality remain high, especially when associated to hemodynamic instability or right ventricular dysfunction. Prognostic stratification to identify high risk patients needing to receive more aggressive pharmacological and closer monitoring is of utmost importance. Modern guidelines for management of acute PE are based on risk stratification using either clinical, radiological, or laboratory findings. This article reviews the modern treatment of acute PE, which is customized upon patient prognosis. Accordingly the current risk stratification tools described in the literature such as clinical scores, echocardiography, helical computer tomography, and biomarkers will be reviewed.

Keywords: pulmonary embolism, prognosis, troponin, BNP, NT-proBNP, echocardiography, computer tomography

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

Pulmonary embolism in the elderly: a review on clinical, instrumental and laboratory presentation

Luca Masotti, Patrick Ray, Marc Righini, Gregoire Le Gal, Fabio Antonelli, et al

Vascular Health and Risk Management 2008, 4:629-636

Published Date: 30 June 2008

Readers of this article also read:

Alveolar dead space and capnographic variables before and after thrombolysis in patients with acute pulmonary embolism

Marcos Mello Moreira, Renato G G Terzi, Carlos Heitor N Carvalho, Antonio Francisco de Oliveira Neto, Mônica Corso Pereira, Ilma Aparecida Paschoal

Vascular Health and Risk Management 2009, 5:9-12

Published Date: 24 November 2008

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors

Eduardo Pimenta, Suzanne Oparil

Vascular Health and Risk Management 2009, 5:453-463

Published Date: 19 May 2009

Treatment of pediatric pulmonary hypertension

Amy Hawkins, Robert Tulloh

Vascular Health and Risk Management 2009, 5:509-524

Published Date: 3 June 2009

Daunorubicin-loaded magnetic nanoparticles of Fe3O4 overcome multidrug resistance and induce apoptosis of K562-n/VCR cells in vivo

Bao-an Chen, Bin-bin Lai, Jian Cheng, et al

International Journal of Nanomedicine 2009, 4:201-208

Published Date: 23 September 2009

Antipsychotic adherence, switching, and health care service utilization among Medicaid recipients with schizophrenia

Douglas L Noordsy, Glenn A Phillips, Daniel E Ball, et al

Patient Preference and Adherence 2010, 4:263-271

Published Date: 20 July 2010

Deep vein thrombosis: a clinical review

Kesieme EB, Kesieme CN, Jebbin N, Irekpita E, Dongo A

Journal of Blood Medicine 2011, 2:59-69

Published Date: 29 April 2011

Antibiofilm surface functionalization of catheters by magnesium fluoride nanoparticles

Lellouche J, Friedman A, Lahmi R, Gedanken A, Banin E

International Journal of Nanomedicine 2012, 7:1175-1188

Published Date: 1 March 2012

Lebrikizumab in the personalized management of asthma

Thomson NC, Patel M, Smith AD

Biologics: Targets and Therapy 2012, 6:329-335

Published Date: 14 September 2012

Endoglin: a critical mediator of cardiovascular health

Kapur NK, Morine KJ, Letarte M

Vascular Health and Risk Management 2013, 9:195-206

Published Date: 6 May 2013